Filing Details

Accession Number:
0001213900-25-070759
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-08-01 18:05:03
Reporting Period:
2025-07-30
Filing Date:
2025-08-01
Accepted Time:
2025-08-01 18:05:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
2032966 Acuren Corp TIC Services-Business Services, Nec (7389) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2042765 Talman Pizzey C/O Acuren Corporation
14434 Medical Complex Drive, Suite 100
Tomball TX 77377
Chief Executive Officer Yes Yes No No
Transaction Summary
Number of Shares After Transactions: 436,667 shares
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-07-30 36,667 $0.00 436,667 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2025-07-30 36,667 $0.00 36,667 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
73,333 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Performance Based Restricted Stock Units $0.00 110,000 110,000 Direct
Common Stock Restricted Stock Units $0.00 73,333 73,333 Direct
Common Stock Performance Based Restricted Stock Units $0.00 146,667 146,667 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
110,000 110,000 Direct
73,333 73,333 Direct
146,667 146,667 Direct
Footnotes
  1. On July 30, 2025, 36,667 of the Reporting Person's restricted stock units were settled for an equal number of shares of the Issuer's Common Stock.
  2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  3. These restricted stock units vest 33 1/3% on the first through third anniversaries of the grant date (July 30, 2024).
  4. Each performance based restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
  5. Subject to the volume weighted average price ("VWAP") of the Issuer's Common Stock reaching a specified price over a ten (10) consecutive trading day period at any time during the period commencing on February 18, 2025 and ending on July 30, 2029 (the "VWAP Achievement Period"), these performance based restricted stock units shall vest on the later of (x) July 30, 2025 and (y) the calendar day following the last day of the VWAP Achievement Period.
  6. These restricted stock units vest on the third anniversary of the grant date (April 11, 2025).
  7. These performance restricted stock units have a three-year performance period and to the extent earned will vest on April 11, 2028. The number of shares of Common Stock that will be earned is subject to decrease based on the results of the performance condition.